Y Mabs Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Y Mabs Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Y Mabs Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Y Mabs Therapeutics by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $898k | 55k | 16.26 |
| 2023-12-31 | $368k | 54k | 6.82 |
| 2023-09-30 | $299k | 55k | 5.45 |
| 2023-06-30 | $358k | 53k | 6.79 |
| 2023-03-31 | $244k | 49k | 5.02 |
| 2022-12-31 | $238k | 49k | 4.88 |
| 2022-09-30 | $675k | 47k | 14.42 |
| 2022-06-30 | $658k | 44k | 15.12 |
| 2022-03-31 | $429k | 36k | 11.89 |
| 2021-12-31 | $590k | 36k | 16.20 |
| 2021-09-30 | $1.1M | 37k | 28.55 |
| 2021-06-30 | $1.2M | 35k | 33.81 |
| 2021-03-31 | $1.1M | 36k | 30.23 |
| 2020-12-31 | $1.9M | 39k | 49.51 |
| 2020-09-30 | $1.4M | 37k | 38.38 |
| 2020-06-30 | $1.8M | 42k | 43.20 |
| 2020-03-31 | $732k | 28k | 26.10 |
| 2019-12-31 | $851k | 27k | 31.26 |
| 2019-09-30 | $575k | 22k | 26.07 |
| 2019-06-30 | $490k | 21k | 22.86 |